EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Implementation of Machine Learning Algorithms to Screen for Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: An In-Depth Explanatory Analysis

Shoham Dabbah, Itamar Mishani, Yana Davidov, Ziv Ben Ari

Digestion · 2024

DOI: 10.1159/000542241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestion, 2024. Verfasst von Shoham Dabbah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Liver Diseases Center, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Machine Learning, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to train machine learning algorithms (MLAs) to detect advanced fibrosis (AF) in metabolic dysfunction-associated steatotic liver disease (MASLD) patients at the level of primary care setting and to explain the predictions to ensure responsible use by clinicians.

Methods

Readily available features of 618 MASLD patients followed up at a tertiary center were used to train five MLAs. AF was defined as liver stiffness ≥9.3 kPa, measured via 2-dimension shear wave elastography (n = 495) or liver biopsy ≥F3 (n = 123). MLAs were compared to Fibrosis-4 index (FIB-4) and non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS) on 540 MASLD patients from the primary care setting as validation. Feature importance, partial dependence, and shapely additive explanations (SHAPs) were utilized for explanation.

Results

Extreme gradient boosting (XGBoost) achieved an AUC = 0.91, outperforming FIB-4 (AUC = 0.78) and NFS (AUC = 0.81, both p < 0.05) with specificity = 76% versus 59% and 48% for FIB-4 ≥1.3 and NFS ≥−1.45, respectively (p < 0.05). Its sensitivity (91%) was superior to FIB-4 (79%). XGBoost confidently excluded AF (negative predictive value = 99%) with the highest positive predictive value (31%), superior to FIB-4 and NFS (all p < 0.05). The most important features were HbA1c and gamma glutamyl transpeptidase (GGT) with a steep increase in AF probability at HbA1c >6.5%. The strongest interaction was between AST and age. XGBoost, but not logistic regression, extracted informative patterns from ALT, low-density lipoprotein cholesterol, and alkaline phosphatase (p < 0.001). One-quarter of the false positives (FPs) were correctly reclassified with only one additional false negative based on the SHAP values of GGT, platelets, and ALT which were found to be associated with a FP classification.

Conclusions

An explainable XGBoost algorithm was demonstrated superior to FIB-4 and NFS for screening of AF in MASLD patients at the primary care setting. The algorithm also proved safe for use as clinicians can understand the predictions and flag FP classifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningLiver CirrhosisNon-alcoholic Fatty Liver DiseaseFatty LiverHumansMaleFemaleMiddle AgedElasticity Imaging TechniquesAdultAlgorithmsLiverSeverity of Illness IndexBiopsyPredictive Value of TestsSensitivity and SpecificityAged

Stichwörter der Autor:innen

Explainable artificial intelligenceLiver fibrosisMachine learningMetabolic dysfunction-associated steatotic liver diseaseScreening

Autor:innen und Institutionen

  • Liver Diseases Center, Sheba Medical Center, Ramat Gan, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Division of Internal Medicine, Sheba Medical Center, Ramat Gan, Israel.
  • Robotics Institute, Carnegie-Mellon University, Pittsburgh, Pennsylvania, USA.

Zitieren

APA

Dabbah, S., Mishani, I., Davidov, Y., & Ben Ari, Z. (2024). Implementation of Machine Learning Algorithms to Screen for Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: An In-Depth Explanatory Analysis. Digestion. https://doi.org/10.1159/000542241

Vancouver

Dabbah S, Mishani I, Davidov Y, Ben Ari Z. Implementation of Machine Learning Algorithms to Screen for Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: An In-Depth Explanatory Analysis. Digestion. 2024. doi:10.1159/000542241

BibTeX
@article{Dabbah2024,
  author = {Dabbah, Shoham and Mishani, Itamar and Davidov, Yana and Ben Ari, Ziv},
  title = {Implementation of Machine Learning Algorithms to Screen for Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: An In-Depth Explanatory Analysis},
  journal = {Digestion},
  year = {2024},
  doi = {10.1159/000542241}
}
Kostenlos starten →